NO178931C - Fremgangsmåte for fremstilling av et hovedsakelig rent, terapeutisk aktivt antigent protein, og ekspresjonssystem bestående av et rekombinant virus - Google Patents

Fremgangsmåte for fremstilling av et hovedsakelig rent, terapeutisk aktivt antigent protein, og ekspresjonssystem bestående av et rekombinant virus

Info

Publication number
NO178931C
NO178931C NO870475A NO870475A NO178931C NO 178931 C NO178931 C NO 178931C NO 870475 A NO870475 A NO 870475A NO 870475 A NO870475 A NO 870475A NO 178931 C NO178931 C NO 178931C
Authority
NO
Norway
Prior art keywords
preparation
expression system
therapeutically active
recombinant virus
antigenic protein
Prior art date
Application number
NO870475A
Other languages
English (en)
Norwegian (no)
Other versions
NO870475D0 (no
NO870475L (no
NO178931B (no
Inventor
Joseph P Brown
Gregory D Plowman
Karl Erik Hellstroem
Anthony F Purchio
Sridhar Pennathur
Charles D Estin
Timothy M Rose
Ingegerd Hellstroem
Shiu-Lok Hu
Original Assignee
Oncogen
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26676698&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO178931(C) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US07/007,230 external-priority patent/US5262177A/en
Application filed by Oncogen filed Critical Oncogen
Publication of NO870475D0 publication Critical patent/NO870475D0/no
Publication of NO870475L publication Critical patent/NO870475L/no
Priority to NO921496A priority Critical patent/NO921496D0/no
Publication of NO178931B publication Critical patent/NO178931B/no
Publication of NO178931C publication Critical patent/NO178931C/no

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/5743—Specifically defined cancers of skin, e.g. melanoma
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens
    • A61K39/00119—Melanoma antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/79—Transferrins, e.g. lactoferrins, ovotransferrins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Mycology (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • General Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Hospice & Palliative Care (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
NO870475A 1986-02-07 1987-02-06 Fremgangsmåte for fremstilling av et hovedsakelig rent, terapeutisk aktivt antigent protein, og ekspresjonssystem bestående av et rekombinant virus NO178931C (no)

Priority Applications (1)

Application Number Priority Date Filing Date Title
NO921496A NO921496D0 (no) 1986-02-07 1992-04-15 Fremgangsmaate for fremstilling av et peptid eller proteinbeslektet med det melanomaforbundne p97-antigen

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US82731386A 1986-02-07 1986-02-07
US07/007,230 US5262177A (en) 1986-02-07 1987-01-27 Recombinant viruses encoding the human melanoma-associated antigen

Publications (4)

Publication Number Publication Date
NO870475D0 NO870475D0 (no) 1987-02-06
NO870475L NO870475L (no) 1987-08-10
NO178931B NO178931B (no) 1996-03-25
NO178931C true NO178931C (no) 1996-07-03

Family

ID=26676698

Family Applications (1)

Application Number Title Priority Date Filing Date
NO870475A NO178931C (no) 1986-02-07 1987-02-06 Fremgangsmåte for fremstilling av et hovedsakelig rent, terapeutisk aktivt antigent protein, og ekspresjonssystem bestående av et rekombinant virus

Country Status (18)

Country Link
JP (3) JP2664673B2 (sv)
BE (1) BE1000175A3 (sv)
CH (1) CH675424A5 (sv)
DE (1) DE3703702C2 (sv)
DK (1) DK63287A (sv)
ES (2) ES2012815A6 (sv)
FI (1) FI94836C (sv)
GR (1) GR870195B (sv)
HU (1) HU209144B (sv)
IE (1) IE59597B1 (sv)
IT (1) IT1222359B (sv)
MX (1) MX9203574A (sv)
NL (1) NL8700285A (sv)
NO (1) NO178931C (sv)
NZ (1) NZ219192A (sv)
OA (1) OA08478A (sv)
PT (1) PT84255B (sv)
SE (2) SE506024C2 (sv)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19821925A1 (de) * 1998-05-15 1999-11-18 Roehnisch Tim Verfahren zur Herstellung einer Zusammensetzung zur Induktion einer tumorspezifischen Immunantwort, sowie Verwendung der Zusammensetzung zur Behandlung von Neoplasien
JP4414023B2 (ja) * 1999-08-05 2010-02-10 オリエンタル酵母工業株式会社 関節炎関連メラノトランスフェリンの測定方法および試薬
JP4708027B2 (ja) * 2002-10-01 2011-06-22 ノバルティス バクシンズ アンド ダイアグノスティックス，インコーポレーテッド 抗癌組成物および抗感染疾患組成物ならびにこれらを使用する方法
US8207314B2 (en) * 2003-05-16 2012-06-26 Sanofi Pasteur Limited Tumor antigens for prevention and/or treatment of cancer

Also Published As

Publication number Publication date
NZ219192A (en) 1991-10-25
IE59597B1 (en) 1994-03-09
FI94836C (sv) 1995-11-10
HU209144B (en) 1994-03-28
FI870501A0 (sv) 1987-02-06
DK63287D0 (da) 1987-02-06
IT1222359B (it) 1990-09-05
FI870501A (sv) 1987-08-08
PT84255A (en) 1987-03-01
ES2012815A6 (es) 1990-04-16
OA08478A (fr) 1988-07-29
DK63287A (da) 1987-08-08
SE9202934D0 (sv) 1992-10-07
HUT43107A (en) 1987-09-28
NO870475D0 (no) 1987-02-06
SE8700466L (sv) 1987-08-08
NL8700285A (nl) 1987-09-01
JPH09135692A (ja) 1997-05-27
IT8719291A0 (it) 1987-02-06
SE8700466D0 (sv) 1987-02-06
PT84255B (pt) 1989-11-30
SE506024C2 (sv) 1997-11-03
JPS62294698A (ja) 1987-12-22
JPH08280390A (ja) 1996-10-29
NO870475L (no) 1987-08-10
JP2664673B2 (ja) 1997-10-15
ES2017258A6 (es) 1991-01-16
FI94836B (sv) 1995-07-31
GR870195B (en) 1987-06-10
BE1000175A3 (fr) 1988-07-12
IE870319L (en) 1987-08-07
DE3703702C2 (de) 1997-07-10
CH675424A5 (en) 1990-09-28
DE3703702A1 (de) 1988-02-18
MX9203574A (es) 1992-07-01
NO178931B (no) 1996-03-25

Similar Documents

Publication Publication Date Title
FI860484A0 (sv) Förfarande för framställning av terapeutiskt aktiva peptidföreningar
DE3751537D1 (de) Polypeptid- und Proteinderivate und Verfahren zu deren Herstellung.
NO180362C (no) Fremgangsmåte for fremstilling av cyklosporinholdige preparater
NO175716C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive, totale og partielle hyaluronsyre-estere
DK662887D0 (da) Fladeformigt terapeutisk system, fremgangsmaade til fremstilling deraf og anvendelse deraf
NO174105C (no) Analogifremgangsmåte for fremstilling av antikoagulerende peptider
NZ209590A (en) Gamma interferon analogue, preparation and pharmaceutical composition
FR2620459B1 (fr) Virus recombinant de la vaccine
DK272688D0 (da) Vaccine og fremgangsmaade til fresmtilling deraf
HUT44619A (en) Process for preparing monoclonal antibodies and peptides suitable for the treatment and detection of hiv infections
DK413987D0 (da) Farmaceutiske praeparater
EP0252392A3 (en) Viral inactivation and purification of active proteins
DE3685651D1 (de) Den antigenischen und immunogenischen determinanten von wichtigen neutralisierenden proteinen des rotavirus entsprechende peptide.
DK652787A (da) Farmaceutiske praeparater
PT85461A (en) Process for preparing recombinant htlv-iii proteins and uses thereof
NO176100C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive oksodihydropyridyl- og oksodihydropyridazinylkromanderivater
NO178931C (no) Fremgangsmåte for fremstilling av et hovedsakelig rent, terapeutisk aktivt antigent protein, og ekspresjonssystem bestående av et rekombinant virus
NO176105C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive peptidderivater
DK37187A (da) Farmaceutisk praeparat til prophylaxe og behandling af virusinfektioner
LTIP1795A (en) Process for preparing protein derived from the envelope gene of human immunodeficiency virus type i and a vaccine containing said protein
PT87207A (pt) Process for preparing recombinant htlv-iii proteins and uses thereof
PT87332A (pt) Method of purification of product of expression of recombinant ferment
IL86699A0 (en) Cell system for expression of recombinant protein without production of virus
DK94087D0 (da) Oprenset human angiogenfaktor, fremgangsmaade til dens fremstilling, og farmaceutiske praeparater
DK290187D0 (da) Peptidderivater og fremgangsmaade til fremstilling deraf